OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2663-2672
Open Access | Times Cited: 55
Giovanni Paoletti, Danilo Di Bona, Derek K. Chu, et al.
Allergy (2021) Vol. 76, Iss. 9, pp. 2663-2672
Open Access | Times Cited: 55
Showing 1-25 of 55 citing articles:
Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
The Lancet Regional Health - Europe (2021) Vol. 13, pp. 100275-100275
Open Access | Times Cited: 104
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
The Lancet Regional Health - Europe (2021) Vol. 13, pp. 100275-100275
Open Access | Times Cited: 104
Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Hot topics in allergen immunotherapy, 2023: Current status and future perspective
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27
Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3584-3592
Open Access | Times Cited: 35
Christian Vogelberg, Ludger Klimek, Bernd Brüggenjürgen, et al.
Allergy (2022) Vol. 77, Iss. 12, pp. 3584-3592
Open Access | Times Cited: 35
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper
Jasper H. Kappen, Zuzana Diamant, Ioana Agache, et al.
Allergy (2023) Vol. 78, Iss. 11, pp. 2835-2850
Open Access | Times Cited: 15
Jasper H. Kappen, Zuzana Diamant, Ioana Agache, et al.
Allergy (2023) Vol. 78, Iss. 11, pp. 2835-2850
Open Access | Times Cited: 15
Long-term efficacy of house dust mite sublingual immunotherapy on clinical and pulmonary function in patients with asthma and allergic rhinitis
Makoto Hoshino, Kenta Akitsu, Junichi Ohtawa, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100206-100206
Open Access | Times Cited: 5
Makoto Hoshino, Kenta Akitsu, Junichi Ohtawa, et al.
Journal of Allergy and Clinical Immunology Global (2024) Vol. 3, Iss. 2, pp. 100206-100206
Open Access | Times Cited: 5
Biologics in severe asthma: the role of real-world evidence from registries
Giovanni Paoletti, J. Pepys, Marta Casini, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210278-210278
Open Access | Times Cited: 22
Giovanni Paoletti, J. Pepys, Marta Casini, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210278-210278
Open Access | Times Cited: 22
New approaches in childhood asthma treatment
Riccardo Castagnoli, Ilaria Brambilla, Mattia Giovannini, et al.
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 23, Iss. 4, pp. 319-326
Open Access | Times Cited: 11
Riccardo Castagnoli, Ilaria Brambilla, Mattia Giovannini, et al.
Current Opinion in Allergy and Clinical Immunology (2023) Vol. 23, Iss. 4, pp. 319-326
Open Access | Times Cited: 11
Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy (BRIT )
Michel Erlewyn‐Lajeunesse, Luciano Perfetti Villa, Shifa Shaikh, et al.
Clinical & Experimental Allergy (2025)
Open Access
Michel Erlewyn‐Lajeunesse, Luciano Perfetti Villa, Shifa Shaikh, et al.
Clinical & Experimental Allergy (2025)
Open Access
ARIA–Italy managing allergic rhinitis and asthma in a changing world: The role of the Pharmacist
Giovanni Paoletti, Corrado Giua, Alessandro Marti, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 5, pp. 101055-101055
Closed Access
Giovanni Paoletti, Corrado Giua, Alessandro Marti, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 5, pp. 101055-101055
Closed Access
Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
Oliver Pfaar, Hartmut Richter, Angelika Sager, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 10
Oliver Pfaar, Hartmut Richter, Angelika Sager, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 10
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
Bernardo Sousa‐Pinto, Luís Filipe Azevedo, Ana Sá‐Sousa, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 14
Bernardo Sousa‐Pinto, Luís Filipe Azevedo, Ana Sá‐Sousa, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 14
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce
Julijana Asllani, Dimitrios Mitsias, George Ν. Konstantinou, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 8
Julijana Asllani, Dimitrios Mitsias, George Ν. Konstantinou, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 8
Effects of allergen immunotherapy in the MASK‐air study: a proof‐of‐concept analysis
Oliver Pfaar, Bernardo Sousa‐Pinto, Philippe Devillier, et al.
Allergy (2021) Vol. 76, Iss. 10, pp. 3212-3214
Open Access | Times Cited: 19
Oliver Pfaar, Bernardo Sousa‐Pinto, Philippe Devillier, et al.
Allergy (2021) Vol. 76, Iss. 10, pp. 3212-3214
Open Access | Times Cited: 19
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy
Danilo Di Bona, Palma Carlucci, Federico Spataro, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 6, pp. 610-625
Closed Access | Times Cited: 7
Danilo Di Bona, Palma Carlucci, Federico Spataro, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 6, pp. 610-625
Closed Access | Times Cited: 7
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis
Cristiano Caruso, Paolo Cameli, Elena Altieri, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Cristiano Caruso, Paolo Cameli, Elena Altieri, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
Good clinical practice recommendations in allergen immunotherapy: Position paper of the Brazilian Association of Allergy and Immunology – ASBAI
Fernando Monteiro Aarestrup, Ernesto Akio Taketomi, Clóvis Eduardo Santos Galvão, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 10, pp. 100697-100697
Open Access | Times Cited: 11
Fernando Monteiro Aarestrup, Ernesto Akio Taketomi, Clóvis Eduardo Santos Galvão, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 10, pp. 100697-100697
Open Access | Times Cited: 11
Treatment with the SQ tree sublingual immunotherapy tablet is safe and well tolerated in real‐life
Oliver Pfaar, Hendrik Wolf, Rainer Reiber, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 2
Oliver Pfaar, Hendrik Wolf, Rainer Reiber, et al.
Clinical and Translational Allergy (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 2
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis
Danilo Di Bona, Giovanni Paoletti, Derek K. Chu, et al.
Clinical and Translational Allergy (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 14
Danilo Di Bona, Giovanni Paoletti, Derek K. Chu, et al.
Clinical and Translational Allergy (2021) Vol. 11, Iss. 4
Open Access | Times Cited: 14
Advances in allergen‐specific immune cell measurements for improved detection of allergic sensitization and immunotherapy responses
Menno C. van Zelm, Craig I. McKenzie, Nirupama Varese, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3374-3382
Closed Access | Times Cited: 14
Menno C. van Zelm, Craig I. McKenzie, Nirupama Varese, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3374-3382
Closed Access | Times Cited: 14
Real-world evidence: Methods for assessing long-term health and effectiveness of allergy immunotherapy
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 881-883
Open Access | Times Cited: 13
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 881-883
Open Access | Times Cited: 13
Mechanisms of allergen immunotherapy supporting its disease-modifying effect
Roxana Silvia Bumbăcea, Rama Boustani, Carmen Panaitescu, et al.
Immunotherapy (2022) Vol. 14, Iss. 8, pp. 627-638
Closed Access | Times Cited: 9
Roxana Silvia Bumbăcea, Rama Boustani, Carmen Panaitescu, et al.
Immunotherapy (2022) Vol. 14, Iss. 8, pp. 627-638
Closed Access | Times Cited: 9
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
Julijana Asllani, Dimitrios Mitsias, George Ν. Konstantinou, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 5
Julijana Asllani, Dimitrios Mitsias, George Ν. Konstantinou, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 6
Open Access | Times Cited: 5
Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
Bernardo Sousa‐Pinto, Oliver Pfaar, Jean Bousquet
Allergologie select (2023) Vol. 7, Iss. 1, pp. 47-56
Open Access | Times Cited: 4
Bernardo Sousa‐Pinto, Oliver Pfaar, Jean Bousquet
Allergologie select (2023) Vol. 7, Iss. 1, pp. 47-56
Open Access | Times Cited: 4
